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Abstract 
Defining the mechanisms underlying the programming of early life growth is fundamental for 
improving adult health and wellbeing. While the association between maternal diet, offspring growth 
and adult disease risk is well-established, the effect of father’s diet on offspring development are 
largely unknown. Therefore, we fed male mice an imbalanced low protein diet (LPD) to determine 
the impact on post-fertilisation development and fetal growth. We observed that in preimplantation 
embryos derived from LPD fed males, expression of multiple genes within the central metabolic 
AMPK pathway was reduced. In late gestation, paternal LPD programmed increased fetal weight, 
however, placental weight was reduced, resulting in an elevated fetal:placental weight ratio. Analysis 
of gene expression patterns revealed increased levels of transporters for calcium, amino acids and 
glucose within LPD placentas. Furthermore, placental expression of the epigenetic regulators Dnmt1 
and Dnmt3L were increased also, coinciding with altered patterns of maternal and paternal imprinted 
genes. More strikingly, we observed fetal skeletal development was perturbed in response to paternal 
LPD. Here, while offspring of LPD fed males possessed larger skeletons, their bones comprised lower 
volumes of high mineral density in combination with reduced maturity of bone apatite. These data 
offer new insight in the underlying programming mechanisms linking poor paternal diet at the time 
of conception with the development and growth of his offspring.  
 
 
 
Keywords: Blastocyst metabolism; Bone health; Developmental programming; Fetal growth; 
Paternal diet; Placental function.  
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Abbreviations 
 
AMPK 5' AMP-activated protein kinase 
DOHaD  Developmental Origins of Health and Disease  
E  Embryonic day 
FWHM Full width at half maximum 
LPD   Low protein diet 
mTORC1 mechanistic Target of Rapamycin complex 1 
NPD   Normal protein diet 
SXRD   Synchrotron x-ray diffraction 
µ-CT  micro-computed tomography  
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1. Introduction 
It is estimated that up to 60% of global mortality is attributed to non-communicable diseases such as 
type 2 diabetes, obesity and heart disease [1]. Typically, the risk for developing such disorders is 
associated with adult lifestyle factors including poor diet, lack of exercise and smoking. However, 
strong associations between maternal nutrition, fetal growth, weight at birth and an increased risk for 
adult-onset ill-health have been identified [2, 3]. The Developmental Origins of Health and 
Disease (DOHaD) hypothesis identifies perturbed early life growth and nutrition as critical factors in 
determining adult risk for cardiovascular and metabolic disease. In addition, links between growth 
during prenatal and postnatal development and degenerative disorders such as osteoporosis have also 
been identified [2]. Central to elucidating the biological mechanisms underlying the programming of 
long-term ill-health has been the use of animal models. For example, modification of maternal diet 
or metabolic status in rodents exclusively during the preimplantation period of development has been 
shown to impact negatively on blastocyst metabolism and redox status [4-7], resulting in persistent 
changes in offspring growth, adult metabolic homeostasis and cardiovascular function [8-10]. Studies 
have identified that during sub-optimal environmental conditions, the preimplantation embryo 
initiates cellular and physiological mechanisms intended to support maximal post-implantation 
development and survival [4, 10, 11]. However, the long-term consequences of these embryonic 
adaptive responses can increase cardio-metabolic and bone health disease risk in later life. Such 
studies reveal the dynamic interaction between the embryo and the immediate environment, as well 
as the long-term impacts for offspring health. 
 
Post-implantation, the development and function of the placenta is central in the regulation of fetal 
growth. Changes in placental function may result in differential transfer of essential nutrients between 
maternal and fetal systems, programming altered fetal growth. We have shown that in response to 
maternal low protein diet (LPD, 9% protein) fed exclusively during the preimplantation period, early 
post-implantation trophoblast outgrowths display increased spreading and cell division phenotypes 
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[4, 12]. Studies feeding pregnant mice [13] and rats [14] a LPD identify changes in placental 
mechanistic Target of Rapamycin complex 1 (mTORC1) and amino acid transporter protein 
expression, as well as perturbed gene expression for apoptosis, growth inhibition and DNA 
methylation processes. In addition, changes in placental structure, nutrient uptake and transport have 
also been reported in response to maternal diet [15-18]. These studies indicate that appropriate 
placental development and function plays a pivotal role in directing fetal growth, an essential 
indicator of postnatal offspring phenotype and disease risk. 
 
While the consequences of manipulating the maternal environment have received extensive 
investigation, the impact of paternal nutrition on the development and growth of his offspring remains 
poorly defined. However, there is now a growing body of clinical, epidemiological and animal model 
data highlighting new associations between paternal physiological status and offspring health [19]. 
Studies in humans and mice have demonstrated that elevated paternal BMI impacts negatively on 
sperm quantity, quality, DNA integrity and male reproductive fitness [20-23]. Post-fertilisation, poor 
paternal diet disrupts blastocyst metabolism [24], skeletal formation [25], neonatal hepatic lipid and 
cholesterol biosynthesis, IGF-1 and corticosterone levels [26, 27], pancreatic β-cell function [28] and 
adiposity [29]. Using the well-characterised rodent LPD model, we demonstrated previously that 
offspring from LPD fed male mice were heavier at birth, displayed elevated adult adiposity, glucose 
intolerance, cardiovascular dysfunction and elevated serum TNF-α when compared to offspring from 
normal protein diet (NPD; 18% protein) fed males [30].   
 
As enhanced perinatal growth is a significant risk factor for adult health status, the aim of our current 
study was to define the mechanisms linking paternal diet with offspring development and growth. 
Here, we report that paternal LPD decreases blastocyst expression of multiple metabolic AMPK 
pathway genes, enhances fetal growth and elevates placental expression of central nutrient 
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transporters and fetal growth regulating imprinted genes. In addition, we observe changes in fetal 
skeletal development and bone mineral deposition patterns.  
 
2. Materials and methods 
2.1 Animal Treatments 
All experimental procedures were conducted using protocols approved by, and in accordance with, 
the UK Home Office Animal (Scientific Procedures) Act 1986 and local ethics committee at Aston 
University. Male (8 week old) and female (8 week old) C57BL/6 mice (Charles River, Oxford, UK) 
were maintained at Aston University Biomedical Facility on a 07:00–19:00 light-dark cycle, 
temperature of 20–22°C with ad libitum access to chow (Special Dietary Services Ltd, UK) and 
water. Male mice were housed singly and allocated either control normal protein diet (NPD; 18 % 
casein; 180 g / kg diet; n = 8) or isocaloric low protein diet (LPD; 9% casein; 90 g / kg diet; n = 8) 
(Special Dietary Services Ltd, UK; Supplementary Table 1; protein content confirmed by 
manufacturer) for between 7 and 9 weeks in total to ensure all stages of spermatogenesis and 
spermiogenesis were exposed to the diets [31]. We have reported previously on the physiological 
impact of LPD on paternal physiology [30], demonstrating no impairment in paternal fertility (sperm 
number, pregnancy rate, litter size), serum glucose, insulin or testosterone levels or in testicular 
weight when compared with NPD fed males. Virgin 8-9 week old C57BL/6 females were caged 
singly overnight with either NPD or LPD studs. Plug positive females were housed singly and 
maintained on chow ad libitum for either collection of blastocysts at E3.5, or late gestation fetal 
tissues at E17.  
 
Blastocysts were flushed from the oviducts and uterus at E3.5 using EmbryoMax KSOM medium 
(Millipore; Catalogue number MR-020P-5F), washed and pooled into groups of 25, frozen in volumes 
<10µl and stored at -80oC ahead of PCR array analysis. At E17, dams were culled via cervical 
dislocation for the collection of fetal and extra-embryonic tissues as described previously [12]. 
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Briefly, individual concepti were dissected from the uterine tissue and weighed prior to separation 
and weighing individually of the fetus, placenta and yolk sac. Fetal heart and liver tissues were 
isolated, weighed, snap frozen in liquid nitrogen and stored. Isolated placentae were either snap frozen 
or fixed in 10% formalin (Sigma, UK) for 24 hours at 4oC prior to storage in 70% ethanol at 4oC. In 
addition, whole fetuses were fixed in 10% formalin (Sigma, UK) for 24 hours at 4oC prior to storage 
in 70% ethanol at 4oC ahead of skeletal analyses.   
 
2.2 Blastocyst AMPK RT2 PCR array 
Total RNA was isolated from eight individual pools of 25 blastocysts (four NPD and four LPD; each 
pool obtained from 4-5 females) using the RNeasy Plus Micro kit (Qiagen, UK) according to the 
manufacturer’s instructions. RNA concentration was assessed using the Qubit fluorometer (Thermo 
Scientific, UK) and equivalent quantities of RNA were converted to cDNA using the RT2 First Strand 
cDNA synthesis kit (Qiagen, UK) according to the manufacturer’s instructions. Expression of 84 
AMPK signalling pathway genes (S1 Table online) were analysed using the AMPK signalling PCR 
array (Qiagen, UK). Amplification was performed on a Stratagene Mx 3000P System (Agilent 
Technologies, CA. USA) with resultant gene expression analysed using web-based PCR Array Data 
Analysis software (www.SAbiosciences.com). 
 
2.3 Tissue metabolite measurement, RNA extraction and transcript expression. 
Flushed day 3.5 maternal uteri were homogenised (50 mM HEPES, 150 mM NaCl, 1 mM EDTA, 1 
mM EGTA, 1% SDS) prior to protein level determination (DC assay, Bio-Rad Laboratories) and 
glucose level analysis by glucose oxidase assay (Sigma, UK) in accordance with the manufacturer’s 
instructions, and measured on a Benchmark microplate reader (Bio-Rad Laboratories, UK).  
 
RNA was isolated from placental and fetal liver using the RNeasy Mini Kit (Qiagen, UK) with 
additional on-column DNase I digestion (Qiagen, UK), prior to cDNA synthesis (nanoScript 2 reverse 
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transcription kit; Primerdesign, UK), all according to manufacturer’s instructions. For Real-Time 
PCR (qRT-PCR), 5 ng cDNA was added to a mastermix comprising 10 µl 2X mastermix (Precision 
SYBRgreen Mastermix; Primerdesign, UK), 5 µM forward and reverse primers and 8.3 µl water per 
reaction. Amplification and detection was performed using a Stratagene Mx 3000P System (Agilent 
Technologies, USA). The expression levels of the samples were calculated using the ΔΔCT method 
with placental data normalised to the expression of Sdha and Tbp and liver tissue data normalised to 
Pgk1 and Tbp [32, 33]. Reaction specificity was confirmed by dissociation curve analysis. Primer 
sequences are provided in Supplementary Table 3. 
 
2.4 Determination of fetal sex and placental histology  
DNA was extracted from fetal tail tissue using the DNeasy Blood and Tissue kit (Qiagen, UK) 
according to the manufacturer’s instruction. For PCR determination of fetal sex, 2 µl (100 ng) of 
template DNA was added to a mastermix comprising 12.5 µl mastermix (2X JumpStart Taq; Sigma), 
2.5 ul primer mix (25 µM forward and reverse primers) and 8 µl water per reaction. Amplification 
was performed using an Eppendorf (Mastercycler® Pro) thermocycler using primers specific for 
regions on the Y (Sry) and X (Dxnds3) chromosomes (primer sequences are provided in 
Supplementary Table 3).  
 
Formalin fixed placentas from five male and five female fetuses per diet group (only one male and 
female taken from any individual dam, n = 5 dams per diet group) were embedded in paraffin wax. 
From each placenta, 4 midsagittal 5 µm sections were taken from the midline of the placenta. Sections 
were mounted onto slides ahead of haematoxylin and eosin staining. Sections were imaged using a      
CETI Magnum-T microscope and a Jenoptik ProgRes CF camera prior to determination of total 
junctional and labyrinthine zone areas using Volocity software. Areas were expressed as proportion 
(percentage) of total midsagittal area comprised by junctional and labyrinthine zones. 
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2.5 Fetal bone analyses  
2.5.1 Whole fetal µ-CT analysis 
Whole formalin fixed fetuses were scanned using a Skyscan 1172 in vivo µ-CT scanner (Bruker, 
Belgium). All scans were taken at 50 kVa and 170 µA with a 0.5 mm aluminium filter, 700 ms 
exposure time, 180o tomographic rotation. Individual two-dimensional cross-sectional images were 
reconstructed using Bruker NRecon software (version 1.6.10) and were analysed using Bruker CTAn 
software (version 1.15). Voxel resolution was 13.5 µm. After 3D reconstruction of each fetal mouse, 
bony tissues were determined by a global threshold that was set using a combination of visual 
inspection of the 2D images and the analysis of associated histograms. Bony tissue was identified in 
all individual fetuses. A threshold for bony tissue was set at 700 Hounsfield Units following visual 
confirmation in all samples. Using this threshold, a clear distinction between bone, surrounding soft 
tissue and ringing artefacts (inconclusive signals near sharp transitions) could be made.  
 
2.5.2 Synchrotron x-ray diffraction (SXRD) 
The right femur and humerus from formalin fixed NPD and LPD fetuses were dissected clean of 
surrounding muscle and connective tissue and stored in 70% ethanol at 4oC. SXRD measurements of 
NPD and LPD offspring fetal femur and humerus bones were conducted at beamline B16 Diamond 
Light Source (Oxford Harwell Campus, Didcot, UK). Bones were mounted normal to the impinging 
X-rays in transmission geometry to allow measurements in two orthogonal directions perpendicular 
to the X-ray beam. An incident X-ray energy of 17 keV was used, equivalent to a wavelength (λ) of 
0.7293 Å, with a beam size of 35 µm.  For each sample, three separate line transects separated by 1 
mm above and below the midline of the bone were scanned in 25 µm increments and an exposure 
time of 60 seconds. Diffraction data was collected using a 2D area detector (Image Star 9000, 
Photonic Science Ltd. UK) with a 3056 x 3056 pixel resolution, placed 110 mm behind the sample 
to give a 2θ range of 5-33°. Measurements were taken also for the direct beam, empty sample 
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containers, beryllium windows and water, with all measurements and instrument parameters 
determined against silicon and lanthanum hexaboride (LaB6) standards. 
 
2.5.3 SXRD data analysis 
Diffraction data were normalised and background corrected using the Fit2D software package 
(version 12.077, ESRF). Diffraction patterns were azimuthally integrated to produce 1D spectra of 
intensity (I) versus the scattering angle (2θ). The Bragg peak corresponding to the (002) (~13°) 
reflection was fitted with a Gaussian peak shape to obtain the peak position and the full width at half 
maximum (FWHM) to quantify possible changes to the crystal structure from the lattice parameters. 
Additionally, Rietveld refinement was used to determine changes in the lattice parameters and texture 
coefficients (General Structure Analysis System package). A hexagonal unit cell with a P63/m 
symmetry space group was assumed for the hydroxyapatite structural model with initial lattice 
parameters [34]. The positions of the (002) and (300) planes were used calculate the hydroxyapatite 
unit cell c and a axis lattice parameters. Peak positions were used to determine the inter-planar spacing 
(d), where 𝑑 = 𝜆/2𝑠𝑖𝑛 𝜃 (here θ is equivalent to half the angle between the incident X-rays and the 
detector), from which lattice parameters were calculated. A hexagonal unit cell was assumed for 
hydroxyapatite, where the relationship between the d spacing, Miller indices for a given Bragg peak 
and lattice parameters are given as;  
1
𝑑2
=
4
3
(
ℎ2 + ℎ𝑘 +  𝑘2
𝑎2
) +  
𝑙2
𝑐2
 
 
2.5.4 Fetal femur Inductive Coupled Plasma (ICP) elemental analysis 
Isolated formalin-fixed fetal right femurs were digested (1 ml concentrated nitric acid, 20 mg of 
ammonium fluoride) using in a CEM SP-D discover microwave digester (190oC for 20 minutes, 
300W power). Samples were diluted with 4 ml of deionised water prior to ICP analysis for calcium 
and phosphorus content using an iCAP 7000 ICP-OES system and measured against AAS standards 
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for calcium and phosphorus (Sigma, UK). The R-squared of the calcium and phosphorus calibration 
curves were 0.9991 and 0.9993 respectively. 
 
2.6 Statistical analyses  
Data were assessed for normality (Shapiro–Wilk test) and correlations between phenotypic 
measurements (Pearson correlation) using SPSS (Version 21). Analysis of fetal weights, bone 
development and placental morphology were analysed using a multilevel random effects regression 
model (SPSS version 21), adjusting for paternal duration on respective diet (number of days), paternal 
origin of litter, gestational litter size and body weight effects where appropriate [10]. Where a 
significant effect of sex was observed, data for each sex were analysed separately and reported as 
such. Significance was taken at P<0.05. 
 
3. Results 
3.1 Paternal LPD reduces blastocyst AMPK signalling pathways gene expression  
Virgin 8-week old female C57BL6 mice were mated with either NPD or LPD fed male C57BL6 mice 
for the collection of mid-late stage (E3.5) blastocysts. We observed no significant difference in the 
mean number of blastocysts collected from NPD or LPD mated females (NPD = 8.6 ± 0.2, LPD = 8.4 
± 0.4; P = 0.84). Four pools of 25 mid-late blastocysts were collected for each paternal dietary group 
ahead of AMPK pathway PCR array analysis. In total, 71 genes were decreased in their relative 
expression and 18 genes were increased in LPD blastocysts (Fig. 1A) (see Supplementary Table 2 for 
array gene list, fold expression differences and individual P values). There was no significant 
difference in the expression of any of the reference genes (Actb, B2m, Gapdh, Gusb, Hsp90ab1) 
between groups (P < 0.1). In LPD blastocysts, 16 genes were identified as being significantly 
decreased in their expression, relative to NPD blastocysts (P < 0.05), while no genes displayed a 
significant increase in expression. Gene function analysis of the differentially expressed genes 
characterised them into the following biological processes: metabolism (Cpt1b, Slc2a4) (Fig. 1B), 
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receptors (Adra1b, Adra2b, Adipor1) (Fig. 1C), transcription regulation (Crtc2, Foxo3, Trp53) (Fig. 
1D), signalling cascades (Akt2, Pdpk1, Prkab1, Ppp2r4) (Fig. 1E) and protein synthesis and 
autophagy (Eef2k, Rb1cc1, Stradb, Ulk1) (Fig. 1F). Analysis of flushed maternal uterine tissue 
revealed significantly lower glucose levels in females mated with LPD fed males; NPD = 2.27 ± 0.21, 
LPD = 1.15 ± 0.28 µg/ml/mg uterus (P = 0.007). 
 
3.2 Fetal growth and placental development are altered by paternal LPD 
As fetal growth is reflective of weight at birth, postnatal growth and adult disease risk, we investigated 
whether paternal LPD influenced late gestation (E17) fetal development. At the time of cull, paternal 
LPD had no effect on mean litter size (NPD = 8, LPD = 8; P = 0.52) or maternal weight gain (NPD 
= 9.3 ± 0.4g, LPD 8.9 ± 0.5g; P = 0.59). In addition, there was no effect of the number of days 
individual males were fed LPD on fetal weight (P = 0.59), placental weight (P = 0.71) or on 
fetal:placental weight ratio (P = 0.66).  In LPD offspring, we observed a similar weight of the 
conceptus (combined fetal, placental and yolk sac weight; P = 0.06) but elevated weight of the isolated 
fetus (P = 0.012), while placental weight was decreased significantly (P = 0.011) (Fig. 2A). There 
was no difference in mean yolk sac weight between groups (Fig. 2A). While fetal heart weight was 
not different between NPD and LPD offspring (data not shown), fetal liver weight was increased 
significantly in LPD offspring (NPD = 42.7 ± 1.0 mg, LPD = 47.0 ± 0.9 mg; P = 0.005). Analysis of 
organ:body weight ratios revealed a significantly decreased fetal:placenta weight ratio (P< 0.0001), 
but no difference in fetal:liver or fetal:heart ratios (Fig. 2B). To determine whether changes in AMPK 
metabolic signalling established within the preimplantation embryo persisted into fetal tissues, we 
determined the expression of 6 genes in the fetal liver differentially expressed from our blastocyst 
array. We chose to study genes involved in a broad range of cellular processes to ascertain the 
potential scope of differences being maintained into late gestation fetal tissues. Here, the expression 
of Adipor1, Akt2, Prkaca, Ppargc1a and Trp53 were all reduced significantly in LPD livers (Fig. 2C; 
P < 0.05), mirroring LPD embryonic expression profiles.  
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3.3 Paternal LPD alters placental morphology and gene expression 
Placental development and function are central regulators of fetal growth. Therefore, we assessed the 
placental morphology and gene expression patterns in response to paternal diet. NPD and LPD 
placentas displayed equivalent mean mid-line placental cross sectional area (Fig. 3B), with no 
differences in mean labyrinth zone, junctional zone or trophoblast areas (Fig. 3B). However, when 
assessed as relative proportions of the whole placental area, a significant reduction in labyrinth and 
increase in junctional zones were observed in LPD placentas (P = 0.028 and 0.002 respectively; Fig. 
3C). As an increased fetal:placental ratio indicates net flux of nutrients to the fetus per gram placenta 
is upregulated, we assessed placental expression of key nutrient transporters. Here, expression of the 
calcium (Atp2b1), neutral amino acid (Slc38a2) and glucose (Slc2a1, Slc2a4) transporters were 
increased significantly in LPD placentas (Fig. 3D, P < 0.05). No difference in the expression of the 
parathyroid hormone receptor (Pthr1) or vitamin D3 receptor (Vdr) were observed between groups. 
In addition, increased expression of DNA methyltransferase 1 and 3L (Dnmt1, Dnmt3L) (Fig. 3E), 
and differential expression of the maternally imprinted Cdkn1c, H19, and Grb10 and paternally 
imprinted Mest and Snrpn genes were observed in LPD placentas (Fig. 3F; all P < 0.05).  
 
3.4 Paternal LPD modifies fetal skeletal development and bone crystallographic morphology 
To determine whether the enhanced fetal growth observed in LPD offspring was driven by changes 
in skeletal formation, we assessed whole fetal skeletal morphology using micro computed 
tomography (µ-CT) (Fig. 4A). Despite there being no difference in whole skeletal bone mineral 
density (Fig. 4B), LPD offspring displayed a significantly increased mean skeletal volume (Fig. 4C, 
P = 0.037). As a consequence of the increased LPD skeletal volume, mean total litter mineral content 
was elevated by 47% (Fig. 4D, P = 0.037). Analysis of whole skeletal mineral distribution, revealed 
an increase in total area of mineralised bone (Fig. 4E), reflective of the increase in bone volume in 
LPD offspring. However, LPD skeletons displayed significantly increased proportions of low mineral 
14 
 
density bone (700-1290 Hounsfield units, Fig. 4F, G, P < 0.0001) but decreased proportions of high 
mineral density bone (1300-1900 Hounsfield units, Fig. 4F, H; P  < 0.01). 
 
To quantify further the impact of paternal diet on offspring bones, we analysed fetal femur and 
humerus hydroxyapatite crystalline structure by X-ray diffraction (Fig. 5B). As no difference in 
hydroxyapatite crystalline structure was observed between humerus and femur bones (data not 
shown), data from each bone were combined and are presented as an average. We observed 
differences in the scattering angle spectra with significant broadening in the LPD bones (Fig. 5C). 
Analysis of a=b lattice (16o scattering angle) and c lattice (13o scattering angle) parameters revealed 
increases in the mean lattice parameters for LPD offspring (Fig. 5D, F; P <0.001) with concordant 
increases in mean lattice full width half maximum values (Fig. 5E, G; P < 0.001). Analysis of the a/c 
lattice ratio revealed similar mean values of 0.707 and 0.709 for NPD and LPD bones respectively. 
To determine whether the changes in hydroxyapatite lattice parameters were as a result of changes in 
bone mineral composition, we performed Inductive Coupled Plasma (ICP) elemental analysis on 
individual fetal femurs. We observed no difference in bone calcium or phosphorus content, or in their 
ratio (Table 1).  
 
4. Discussion 
Defining the mechanisms underlying the aetiology of adult-onset disorders such as obesity, heart 
disease and osteoporosis are of considerable relevance to current human health concerns. Strong 
associations between maternal diet, altered embryonic and fetal development and increased adult-
onset disease risk in her offspring are well established. However, our understanding of the impact 
paternal diet has on post-fertilisation development and adult offspring health remains ill-defined. 
Previously, we demonstrated that a nutritionally imbalanced paternal LPD in mice elevated offspring 
growth, increased adult fat mass, impaired glucose tolerance and cardiovascular function [30]. As 
increased perinatal growth is a significant risk factor for adult health, the aim of this current study 
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was to define the impact of paternal diet on post-fertilisation development and fetal growth regulation. 
In response to paternal LPD, we observed persistent programming of multiple AMPK genes, 
established within the preimplantation embryos and still evident in the late gestation fetal liver. In 
addition, we observed enhanced fetal growth, coinciding with elevated expression of placental 
nutrient transporters and imprinted genes. Finally, we observed that while offspring of LPD males 
had increased skeleton volume, their bones comprised higher volumes of low mineral density.  
 
Paternal LPD reduced blastocyst expression of 16 genes within the central cellular metabolic AMPK 
pathway. We observed decreased expression of genes for receptors, signalling cascades, protein 
synthesis and autophagy, transcription regulation and metabolism biological processes. Of note, we 
observed reductions in the expression of the adiponectin receptor 1 (Adipor1), the facilitated glucose 
transporter 4 (Slc2a4) and the energy sensing non-catalytic subunit of AMPK (Prkab1), as well as 
insulin receptor (Insr; at a trend level). Together, these observations indicate a reduced metabolic 
status within LPD embryos. In response to a drop in intracellular ATP levels, AMPK stimulates the 
uptake of glucose and oxidation of fatty acids and inhibits the synthesis of cholesterol and 
triglycerides [35]. In mammalian preimplantation embryos, glucose is the predominant energy 
substrate with mouse embryos capable of additionally metabolising fatty acids [36]. In both mouse 
and human embryos, while glucose uptake correlates positively with embryonic development, 
blastocoel formation and post implantation survival [37, 38], lower glycolytic rates (the conversion 
of glucose to lactate) are observed in ‘faster’ developing mouse embryos [38]. Conversely, lower 
rates of amino acid and glucose metabolism in human embryos have been attributed to increased 
developmental potential [39]. Therefore, the reduced expression of Slc2a4, Adipor1 and Prkab1 
observed in LPD blastocysts may be a direct adaptive response initiated to modify metabolism in 
order to enhance post-implantation survival.  
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In line with reduced signalling via metabolic receptors, we observed that paternal LPD reduced the 
expression of signal transduction regulators Akt2 and Pdpk1 in LPD blastocysts. Akt and Pdpk1 have 
key roles in the regulation of cellular migration, metabolism mitogenesis, differentiation and survival 
through their down-stream interaction with mTORC1 [40]. In response to growth factor receptor 
signalling, mTORC1 stimulates the biosynthesis of proteins, lipids and nucleic acids via the actions 
of the down-stream substrates ribosomal protein S6 kinase (S6K) and eukaryotic translation initiation 
factor 4E-binding protein (4E-BP) [41]. Changes in mouse blastocyst signalling via the mTORC1 
pathway have been demonstrated in response to uterine amino acid and insulin concentrations [4]. 
Therefore, it cannot be discounted that changes in blastocyst metabolism and downstream signalling 
mechanisms may have occurred in response to paternal modulation of the maternal pre-implantation 
uterine environment. Indeed, we observed reductions in maternal uterine glucose levels at the time of 
implantation in females mated with LPD fed males. Changes in uterine metabolite levels have been 
observed in response to maternal LPD [4] associated with enhanced fetal growth and adult 
cardiovascular and metabolic ill-health in mice [9, 10]. Studies have also shown that seminal plasma 
can impact on rodent, porcine and human female reproductive tract physiology [42, 43]. The presence 
of seminal plasma at the time of mating is essential for the appropriate oviductal expression of several 
embryotrophic factors including Lif, IL6, Csf and Egf and the pro-apoptotic factor Trail in mice [44]. 
In line with these studies, we observed decreased expression of the transformation related protein 53 
(Trp53) in LPD blastocysts. Trp53 acts as a tumour suppressor in many cell types either by reducing 
cell cycle progression or by induction of pro-apoptotic factors. While increased expression of Trp53 
is associated with poor embryonic developmental capacity in both mice and humans [45, 46],  
Trp53-/- mouse blastocysts display increased viability post-transfer and are more likely to result in a 
viable fetus [47]. These data indicate that paternal diet may modify blastocyst metabolism and 
survival directly as well as via modulation of the maternal uterine environment. However, further 
mechanistic studies are required to determine the association of paternal diet with modified 
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preimplantation embryo metabolism and gene expression and their impact on subsequent 
developmental potential.   
 
Our second key finding was that in late gestation, fetal growth was increased in response to paternal 
LPD while placental size was decreased. The mechanisms underlying the reduced size of the mature 
placenta in females mated with LPD fed males remain unclear. Maternal LPD fed exclusively during 
the preimplantation period modifies blastocyst allocation to the trophectoderm lineage with 
consequent changes in trophoblast out-growth phenotype [4, 12]. Therefore, reduced placental weight 
may be reflective of differential cell lineage allocation in the early embryo, driven either by uterine 
changes in specific nutrients and/or perturbed blastocyst metabolic signalling. The observation that 
despite a significant reduction in LPD placental mass, LPD offspring fetal weight was enhanced, 
suggests placental transport flux of nutrients to the fetus was upregulated. Therefore, we determined 
the expression levels of placental transporters central in the regulation of fetal growth. Paternal LPD 
resulted in an increased expression of specific transporters of glucose (Slc2a1, Slc2a4), neutral amino 
acids (Slc38a2) and calcium (Atp2b1). Elevated placental expression and activity of glucose and 
System A and L amino acid transporters are associated with increased fetal growth in women with 
type-1 diabetes [48, 49]. Similarly in obese women, increased amino acid transporter activities 
correlate positively with fetal growth [50], while placental size and calcium transporter gene 
expression have been shown to predict offspring bone mass at birth [51, 52]. Therefore, up-regulation 
of placental nutrient transporter expression appears a central mechanism in the regulation of fetal 
growth, whatever the underlying environmental cause. In contrast, the impact of paternal 
physiological status on placental development has remained largely unexplored. In a mouse model of 
paternal dietary-induced obesity, sex-specific changes in placental expression of Ppara and Casp12 
have been observed [53], while a paternal low folate diet modified placental expression of genes 
associated with gene transduction and cell signalling [25]. Thus, programming of enhanced placental 
nutrient transport may underlie the enhanced fetal growth trajectory induced by paternal LPD. 
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However, the conclusion drawn from our current study are limited by our observations being taken 
only at the gene expression level.  It is essential that our future studies validate these changes at the 
protein level in order to determine fully the impact of paternal diet on fetal growth regulation and the 
underlying mechanisms involved. In addition, it would also be beneficial to measure placental 
function and nutrient transport flux in response to paternal diet.  
 
The paternal epigenome also plays a substantial role in directing fetal growth through regulation of 
placental development and function [54]. In mammals, fetal growth and placental transport of 
nutrients are regulated tightly by the expression of parent-of-origin specific imprinted genes [55]. 
Imprinted genes have evolved to regulate maternal resource allocation to the developing fetus, with 
paternal imprints allocating resources to the fetus and maternal imprints retaining them. In LPD 
placentas we observed increased levels of the maternally-expressed Cdkn1c, H19 and Grb10, while 
the paternally-expressed Mest and Snrpn were increased and decreased respectively. In addition, we 
observed increased Dnmt1 and Dnmt3L expression in LPD placentas. Cdkn1c encodes a cyclin-
dependent kinase inhibitor that negatively regulates cell proliferation [56]. Reduced placental 
expression of Cdkn1c is associated with increased placental size and disproportionate 
labyrinth/junctional zone proportions [56, 57]. Similarly, disruption of the maternal Grb10 allele also 
results in overgrowth of both the placenta and the fetus via enhanced placental efficiency [58, 59]. 
The paternally expressed Mest is restricted to fetal endothelial cells of the labyrinth [60] with loss of 
function resulting in reduced placental size and fetal growth [61]. It was of interest to note that while 
we observed increased expression of H19, no difference in Igf2 was detected. As Igf2 and H19 
expression are regulated reciprocally from the same differentially methylated element, an increase in 
H19 should result in a decrease in expression of Igf2.  However, as we did not measurement parental 
allele-specific expression, or Igf2 at the protein level, this may account for the lack of difference 
observed. Similarly, we did not determine the impact of our observed changes in Dnmt1/3L 
expression on placental gene methylation status or expression profile. Our observations of decreased 
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placental size in conjunction with increased expression of maternal Cdkn1c, H19 and Grb10, as well 
as decreased paternal Snrpn, indicate a maternal adaptive mechanisms to restrict fetal growth in 
response to paternal LPD. However, the increased placental expression of nutrient transporters may 
ultimately result in the elevated fetal growth observed. It is also possible that LPD induced changes 
in paternal gene expression may also influence placental function and offspring development 
independent of direct transmission of genetic effects [62, 63]. Therefore further studies are needed, 
not only to address our study limitations and validate the gene expression changes observed for 
regulators of epigenetic mechanisms, but also to understand the heritability and paternal genomic 
mechanisms of fetal programming.  
 
Our third main finding was that paternal LPD modified the development of the fetal skeleton. While 
the skeletal volume of LPD fetuses was increased, we observed that their bones comprised lower 
levels of high density hydroxyapatite mineral deposition. Studies in humans and rodent models have 
shown that appropriate development of the fetal skeleton appears to be a fundamental prerequisite for 
optimal adult bone health. In humans, fetal femur longitudinal growth predicts skeletal size at age 4 
years [64], and variation in older-adult bone mass is highly correlated with prenatal skeletal 
development and birth weight [65]. Human studies demonstrate also that nutritionally induced delays 
in bone maturation increase hip fracture risk, reduce bone mineral accrual and induce disproportionate 
bone growth in adulthood [66, 67]. In rodents, maternal LPD has been shown to reduce femoral neck 
thickness, trabecular density and femoral and tibia strength in adult offspring [68]. Conversely, a 
paternal low folate diet in mice results in an increase in fetal skeletal defects [25], while sperm DNA 
damage has been associated with embryonic malformations  [69].  These data indicate that while 
paternal LPD promotes overall bone size and skeletal growth, their composition appears sub-optimal. 
 
The changes in offspring bone mineral distribution were observed alongside significant 
crystallographic changes in bone apatite. We observed that in femurs and humerus bones of offspring 
20 
 
from LPD fed males, both a=b and c lattice parameters were increased significantly from those of 
NPD offspring. Such changes are usually ascribed to either compositional variation in the apatite 
crystallites [70, 71] or crystallographic differences relative to the crystallite particle morphology [72] 
manifested due to the presence of internal residual strains. We observed that the ratio of the unit cell 
parameters c/a remained similar between NPD and LPD diets at 0.707 and 0.709 respectively. These 
differences are therefore more likely to be related to growth-rate induced effects than phenomena 
associated with (later) bone maturation where typically the a-lattice decreases whilst the c-lattice 
remains constant [73]. Similarly, the lack of distortion of the unit-cell (lack of changes to the c/a ratio) 
suggests that in this case, differences in macroscopically manifested residual stresses in LPD and 
NPD bone are unlikely to account for the observed changes to the unit-cell as such stresses in bone 
are deviatoric. Within bone the chemical composition of hydroxyapatite varies. Although no 
quantitative phase analysis was undertaken it is well accepted that with bone growth and maturation, 
there is an increase in bone crystallinity, a matched crystallite growth and a reduction in lattice size 
[63]. Changes in the lattice parameters of early forming bone can inform on compositional differences 
of the maturing bone apatite. Studies have demonstrated that the substitution of apatite OH- and PO4 
ions with Cl- and HPO4
2- respectively, significantly lengthens the a=b apatite axis [64], while the 
substitution of PO4 by CO3 increases the apatite c lattice axis [65]. In addition, changes in lattice 
parameters have been identified based on the analysis of calcium and phosphorus content during the 
early stages of ossification in animal [65, 66] and human [63] studies. Here, developing bone is seen 
as a mixture impure hydroxyapatite with calcium-phosphate phases comprising different 
calcium:phosphate ratios. As bones mature, the calcium content increases as a function of age. 
However, our elemental analysis of NPD and LPD fetal femurs revealed no significant difference in 
mean calcium or phosphorus content, or in their relative ratio. One main limitation to elemental 
analysis is that it cannot discriminate between calcium contained within a crystalline state and that 
within more amorphous states. Our data suggests that the more rapid skeletal growth associated with 
the LPD diet is associated with smaller crystallite sizes and increased unit-cell lengths which are in 
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contrast to the expected observation of an increased crystallite size with age/growth rate and a 
reduction of unit-cell lengths bone maturation [70]. These findings indicate undescribed perturbation 
of bone growth with disruption of ‘normal’ mineralization at the ultrastructural level. Although the 
exact physico-chemical mechanisms could not be elucidated there are clear implications on bone 
function and further studies to determine whether this is a delay in ossification or a more permanent 
disruption of ossification are required.   
 
Conclusions 
We have demonstrated that paternal LPD perturbs blastocyst metabolic AMPK gene expression, 
potentially as an adaptive mechanism to preserve embryo viability. Analysis of late gestation fetal 
liver tissues revealed identical expression profiles for several of the same genes indicating persistence 
in paternally programmed metabolic function between the embryo and late gestation differentiated 
tissues. Furthermore, we observed that paternal LPD enhanced fetal growth potentially through 
elevated expression of placental nutrient transporter and modified patterns of imprinted gene 
expression. Finally, we observed that while paternal LPD promoted increased fetal skeletal growth, 
bone mineral distribution was impaired. These studies highlight the importance of paternal nutrition 
at the time of conception for the post-fertilisation development and growth of his offspring. While 
these adaptive changes in developmental trajectory may confer short-term advantage, for example in 
post-implantation survival or post-natal reproductive fitness, they result ultimately in an increased 
predisposition for adult-onset chronic disease in later life. However, our current conclusions are 
limited in their scope and require additional studies to confirm whether our observed changes at the 
gene levels are reflected in changes at the protein levels. In addition, it is essential that we defining 
further the precise mechanisms underlying the programming of offspring development in relation to 
paternal diet.  
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Table 1. Fetal femur weight and Inductive Coupled Plasma (ICP) elemental analysis 
 
 NPD LPD 
Right Femur weight (mg) 0.30  ± 0.02a 0.38  ± 0.02b 
Right Femur calcium content (%/mg bone) 4.29  ± 0.53a 4.12  ± 0.21a 
Right Femur phosphorus content (%/mg bone) 3.52  ± 0.38a 3.47 ± 0.14a 
Right Femur calcium:phosphorus ratio 1.21  ± 0.03a 1.20  ± 0.03a 
 
All data are expressed as mean ± SEM. Different superscript letters denote significance at P < 0.05. n 
= 8 femurs per dietary group, each from different litters. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
34 
 
Fig 1. Paternal LPD modifies preimplantation blastocyst AMPK pathway gene expression. 
Fold expression change in LPD blastocysts for all array genes analysed compared with NPD genes 
(a). Relative LPD E3.5 blastocyst expression of genes involved in (b) metabolism, (c) receptors, (d) 
transcription regulation, (e) signalling cascades and (f) protein synthesis within the AMPK pathway. 
NPD blastocyst expression is normalised to 1; n = 4 pools of 25 blastocysts, each pool generated from 
4-6 females for each dietary group. Expression data was analysed using the web-based PCR Array 
Data Analysis software (www.SAbiosciences.com). Bars in A represent mean with 5-95 percentile. 
Scatter plots display mean ± SEM. *, P < 0.05; **, P < 0.01. 
 
Fig 2. Paternal LPD enhances late gestation fetal growth.  
Mean weight of concepti, fetal and extra-embryonic tissues (a) and fetal:organ weight ratios (b) for 
offspring from NPD and LPD fed males at E17. Fetal liver expression of AMPK pathway genes (C); 
relative expression for NPD fetal livers are normalised to 1. Fetal weights are from a total of 54-59 
individual fetuses from 8 litters per treatment group, each from different males. All data were 
analysed using a multilevel random effects regression analysis. Liver expression data are from 8 
individual fetuses per treatment group, each from separate litters.  Values are mean ± SEM. *, P < 
0.05; ***, P < 0.001. 
 
Fig 3. Paternal LPD modifies late gestation placental development, nutrient transporter and 
imprinted gene expression. 
Representative mid-sagittal histological image of a late gestation placenta displaying the trophoblast 
(Tr), junctional (Jz) and labyrinth (Lz) zone regions (a). Total cross-sectional area of mid-sagittal 
sections of placental tissue and individual regions (b). Relative proportion of trophoblast, junctional 
zone and labyrinth zone as a percentage of the whole cross-sectional area (c). Relative LPD 
expression of placental transporters (d), DNA methyltransferases (e) and imprinted genes (f); 
expression for NPD placentas is normalised to 1. Placental morphology data are from 10 placentas 
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per treatment group (taken from all 8 litters per treatment group). Gene, expression analysis was 
conducted on 8 separate placentas per treatment group, one placenta per litter per treatment group. 
All data were analysed using a multilevel random effects regression analysis. Values are mean ± 
SEM. *, P < 0.05; **, P < 0.01. 
 
Fig 4. Paternal diet increased late gestation fetal skeletal volume but impairs bone mineral 
distribution. 
Representative µ-CT image of a whole E17 fetal skeleton (a). Offspring whole skeletal bone mineral 
density (b). Offspring whole skeletal volume (c). Litter total mineral content (d). Offspring skeletal 
mineral density distribution and area under the distribution curve (insert) (e). z-score transformation 
of offspring skeletal mineral density distribution (f). Area of offspring bone displaying low (g) or 
high (h) mineral density. Values in b, c, d, e, g and h are mean ± SEM. Values in F are standardised 
to a mean of 0 with an SD of 1. All data are from 8 fetuses per treatment group, one fetus per litter 
per treatment group. All data were analysed using a multilevel random effects regression analysis. *, 
P < 0.05; **, P < 0.01; **** P, < 0.0001. 
 
Fig 5. Paternal LPD modifies fetal bone hydroxyapatite crystal structure 
Diagram of atomic organisation and lattice plane orientation of hydroxyapatite (a). Representative X-
ray diffraction pattern showing characteristic 002 and 300 rings (b). X-ray diffraction spectra (Q) 
averaged for NPD and LPD fetal humerus and femur hydroxyapatite (c). NPD and LPD fetal femur 
hydroxyapatite a=b lattice (d), a=b lattice full width half max (e), c lattice (f) and c lattice full with 
half max parameters (g). Values in b-d are mean ± SEM. All data are from 8 fetuses per treatment 
group, one fetus per litter per treatment group. All data were analysed using a multilevel random 
effects regression analysis. ****, P < 0.0001. 
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Fig. 2 
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Fig. 3 
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Fig. 4 
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Fig. 5      
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